Panagora Asset Management Inc. raised its stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 2,095.1% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 155,480 shares of the technology company's stock after acquiring an additional 148,397 shares during the period. Panagora Asset Management Inc. owned approximately 0.07% of AMETEK worth $26,764,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Invesco Ltd. increased its position in shares of AMETEK by 127.2% during the 1st quarter. Invesco Ltd. now owns 3,479,397 shares of the technology company's stock valued at $598,943,000 after purchasing an additional 1,947,831 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of AMETEK by 21.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 10,970,047 shares of the technology company's stock valued at $1,888,385,000 after purchasing an additional 1,908,742 shares during the last quarter. Lazard Asset Management LLC increased its position in shares of AMETEK by 393.1% during the 4th quarter. Lazard Asset Management LLC now owns 1,215,087 shares of the technology company's stock valued at $219,030,000 after purchasing an additional 968,661 shares during the last quarter. GAMMA Investing LLC increased its position in shares of AMETEK by 18,368.3% during the 1st quarter. GAMMA Investing LLC now owns 973,280 shares of the technology company's stock valued at $167,540,000 after purchasing an additional 968,010 shares during the last quarter. Finally, Compagnie Lombard Odier SCmA purchased a new stake in shares of AMETEK during the 1st quarter valued at about $113,317,000. Institutional investors own 87.43% of the company's stock.
AMETEK Trading Down 1.1%
Shares of AME opened at $184.71 on Friday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.63 and a quick ratio of 1.04. AMETEK, Inc. has a 1 year low of $145.02 and a 1 year high of $198.33. The company has a 50 day simple moving average of $181.97 and a two-hundred day simple moving average of $177.03. The firm has a market cap of $42.66 billion, a P/E ratio of 29.74, a price-to-earnings-growth ratio of 2.66 and a beta of 1.10.
AMETEK (NYSE:AME - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.69 by $0.09. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. The business had revenue of $1.78 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same period last year, the firm posted $1.66 EPS. The company's revenue was up 2.5% on a year-over-year basis. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. On average, equities analysts expect that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.
AMETEK Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 15th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Monday, September 15th. AMETEK's dividend payout ratio is currently 19.97%.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on AME. KeyCorp upped their price target on shares of AMETEK from $195.00 to $205.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Melius lowered shares of AMETEK from a "buy" rating to a "hold" rating and set a $192.00 price target for the company. in a research report on Monday, July 14th. Royal Bank Of Canada increased their target price on shares of AMETEK from $209.00 to $212.00 and gave the stock an "outperform" rating in a report on Friday, August 1st. Truist Financial increased their target price on shares of AMETEK from $196.00 to $200.00 and gave the stock a "buy" rating in a report on Monday, May 5th. Finally, Morgan Stanley increased their target price on shares of AMETEK from $185.00 to $198.00 and gave the stock an "equal weight" rating in a report on Friday, August 8th. Seven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $208.00.
View Our Latest Stock Report on AMETEK
About AMETEK
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report